eNOS uncoupling–mediated ICAM-1 nitration stabilizes adhesion molecule expression and drives leukocyte recruitment in senescent endothelium

Hypothesis

In senescent endothelial cells, eNOS uncoupling-generated superoxide preferentially nitrates tyrosine residues on ICAM-1, enhancing its binding affinity for leukocyte integrins and retarding its endocytic turnover. This post‑translational stabilization amplifies leukocyte adhesion and transmigration independent of transcriptional upregulation, creating a redox‑driven feed‑forward loop that sustains the senescence‑associated secretory phenotype (SASP) and vascular inflammation.

Mechanistic rationale

• eNOS uncoupling in senescence shifts NO synthesis to superoxide production [eNOS uncoupling and ROS].
• Superoxide reacts with residual NO to form peroxynitrite, a potent nitrating agent that can modify ICAM-1 tyrosine residues, increasing its affinity for Mac‑1 (CD11b/CD18) on neutrophils and monocytes [ICAM-1 upregulation by TNF-α and shear stress].
• Nitrated ICAM-1 resists clathrin‑mediated internalization, prolonging its half‑life at tricellular junctions and sustaining Src/JNK signaling that disrupts VE-cadherin and barrier integrity [Endothelial senescence and SASP]
• Persistent junctional ICAM-1 maintains leukocyte‑derived cytokine delivery (e.g., TNF-α, IL-1β), which further fuels NF‑κB activation and SASP secretion, closing the loop.

Testable predictions

1. Biochemical – Senescent endothelial lysates will show increased tyrosine‑nitrated ICAM-1 detectable by anti‑nitro‑tyrosine immunoblot, correlating with eNOS uncoupling markers (e.g., BH4/BH2 ratio, dimer/monomer eNOS).
2. Functional – Scavenging superoxide with mito‑TEMPO or restoring BH4 with sepiapterin will reduce ICAM-1 nitration, accelerate its internalization, and decrease leukocyte adhesion under flow, without altering ICAM-1 mRNA levels.
3. Genetic – Expressing a nitration‑resistant ICAM-1 Y→F mutant in senescent ECs will diminish leukocyte transmigration and SASP amplification, despite elevated superoxide.
4. Pharmacological – Inhibiting peroxynitrite formation (FeTPPS) will phenocopy BH4 rescue, confirming that nitration—not merely superoxide—drives the adhesion phenotype.

Experimental approach

• Model: Human umbilical vein endothelial cells (HUVECs) induced senescent by low‑dose doxorubicin or irradiation; validate by SA‑β‑gal, p16^INK4a^ elevation, and SASP cytokine secretion.
• Readouts:
  • ICAM-1 nitration: immunoprecipitation with anti‑ICAM-1 followed by anti‑nitro‑tyrosine Western.
  • Surface half‑life: biotinylation chase assay to measure internalization rate.
  • Leukocyte adhesion: parallel‑plate flow chamber with fluorescent HL‑60 neutrophils under physiological shear.
  • SASP quantification: ELISA for IL‑6, TNF-α, TGF-β.
  • eNOS coupling state: BH4/BH2 HPLC, eNOS dimer/monomer by low‑temperature SDS‑PAGE.
• Interventions: mito‑TEMPO (5 µM), sepiapterin (100 µM), FeTPPS (10 µM), siRNA against eNOS, transfection of ICAM-1 Y→F mutants.

Potential implications

If validated, this hypothesis repositions eNOS uncoupling not merely as a source of oxidative stress but as a direct modulator of adhesion molecule stability, offering a targeted therapeutic avenue: preserving ICAM-1 turnover via BH4 supplementation or peroxynitrite scavenging could attenuate leukocyte‑driven vascular inflammation in aging and atherosclerosis without requiring senolytic clearance of endothelial cells.